SCHEMBL18944367

SCHEMBL18944367

CN1c2cc(Cl)ccc2NCc2cnn(C)c21

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRPF1 P55201 1/20 0.31
▸ RPS6KB1 P23443 1/20 0.31
▸ HSP90AA1 P07900 1/20 0.31
▸ HSP90AB1 P08238 1/20 0.31
▸ LMNA P02545 2/20 0.31
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ OPRK1 P41145 2/20 0.31
▸ PDE4D Q08499 1/20 0.31
▸ NISCH Q9Y2I1 1/20 0.30
▸ NOS1 P29475 2/20 0.30
▸ DYRK1A Q13627 1/20 0.30
▸ CYP11B2 P19099 1/20 0.30
▸ DRD4 P21917 4/20 0.30
▸ DRD2 P14416 3/20 0.30
▸ KAT2B Q92831 1/20 0.30
▸ CHRM1 P11229 2/20 0.30
▸ DRD3 P35462 2/20 0.30
▸ POLB P06746 2/20 0.30
▸ ADRA2A P08913 2/20 0.30
▸ ADRA2B P18089 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14027651 0.80 BRPF1 (0.51) BRPF1SMN1; SMN2KAT2BHTR5AHSD17B10
SCHEMBL9537170 0.75 DRD4 (0.36) LMNASMN1; SMN2OPRK1DRD4DRD2
SCHEMBL30935794 0.74 BRPF1 (0.44) BRPF1LMNASMN1; SMN2OPRK1PDE4D
SCHEMBL29990699 0.74 TSPO (0.34) LMNASMN1; SMN2OPRK1DRD4DRD2
SCHEMBL21379279 0.74 TSPO (0.34) LMNASMN1; SMN2OPRK1DRD4DRD2
SCHEMBL1495860 0.74 TSPO (0.37) LMNASMN1; SMN2OPRK1DRD4DRD2
SCHEMBL22050042 0.72 BRPF1 (0.60) BRPF1LMNASMN1; SMN2OPRK1PDE4D
SCHEMBL9539100 0.64 DRD4 (0.36) DRD4DRD2CHRM1DRD3ADRA2A
SCHEMBL2629041 0.63 TSHR (0.34) SMN1; SMN2DRD4DRD2CHRM1ADRA2A
SCHEMBL30935803 0.63 BRPF1 (0.44) BRPF1LMNASMN1; SMN2OPRK1PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1781661-B1 VASOPRESSIN V1A ANTAGONISTS VANTIA LTD (GB) 2017-06-07 — — EP disclosed
Send feedback